此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Adaptated Physical Activity in Cancerology (APACAN)

2015年12月23日 更新者:Centre Jean Perrin

APACAN study_Adaptated Physical Activity in Cancerology

This trial will measure the fatigue in breast cancer patients.

Two groups of patients will be realised:

  • Arm A: Physical activity during treatment
  • Arm B: No physical activity during treatment but after

The aim of the study is to decrease fatigue, with adequate physical activity, in primary breast cancer patients who receive a treatment for their pathology.

研究概览

地位

终止

条件

详细说明

This is an open monocentric study, randomized in two parallel arms with a waiting list.

The duration of the physical activty will vary according to the duration of the treatment: from 2 to 6 months.

Several questionnaries (fatigue, quality of life, ...) will be given to patients at the inclusion, at the end of the period of treatment and 3 to 6 months after the end of treatment.

One hundred patients are necessary in this study (fifty in each arm). We expect to a stability of the fatigue in Arm A compared to an increase of the fatigue in arm B.

研究类型

介入性

注册 (实际的)

3

阶段

  • 不适用

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 75年 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

女性

描述

Inclusion Criteria:

  • Women aged 18 to 75 years (included)
  • Patient with a breast tumor, regardless of the stage and size (except metastatic patients)
  • Patient with a local recurrence of breast cancer
  • Patient with a second non-metastatic breast cancer
  • Breast cancer treated, regardless of the surgery, at least by radiotherapy, chemotherapy (neoadjuvant or adjuvant) +/- targeted therapy
  • A mandatory social security affiliation.
  • Obtaining informed consent in writing, signed and dated.
  • Medical certificate of fitness to practice physical (issued by the medical oncologist)

Exclusion Criteria:

  • Cancer other than breast cancer and / or associated with breast cancer
  • Metastatic Cancer
  • in case of surgery before treatment, delay before beginning treatment inferior to 1 month post-surgery
  • Men
  • Woman pregnant
  • Patient with cognitive or psychiatric disorders
  • Patients suffering from disability
  • Significant alterations in nutritional status (malnutrition with BMI <19, obese with BMI> 40, BMI)
  • Cardiac contraindication to physical activity
  • Knowledge and understanding of the French language enough not to learn the correct way of self-administered questionnaires or respond to questioning
  • Participation in another clinical study with a similar objective
  • Inability to reach the centers where physical activity takes place

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
其他:Arm A with physical activity during the treatment
In the arm A, patients will realise physical activity during the treatment. Blood samples will be realised. Questionnaries will be given to the patients.
Patients will realise physical activity either during their treatment, either after their treatment. They will have practise a physical activity three times per week.
其他:Arm B with physical activity after the treatment
In the arm B, the physical activity will be realised after treatment. Blood samples will be realised. Questionnaries will be given to the patients.
Patients will realise physical activity either during their treatment, either after their treatment. They will have practise a physical activity three times per week.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Difference between the questionnaries scores MFI 20 (specific fatigue) between baseline and end of treatment.
大体时间:up to 6 months
The scores of fatigue at the end of treatment and at the inclusion will be compared.
up to 6 months

次要结果测量

结果测量
措施说明
大体时间
QLQ-C30
大体时间:up to 6 months
Comparison of the scores of QLQ-C30 assessed at the end of the treatment and at the inclusion.
up to 6 months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Yves Jean Bignon, MD,PhD、Centre Jean Perrin

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2014年9月1日

初级完成 (实际的)

2015年4月1日

研究完成 (实际的)

2015年4月1日

研究注册日期

首次提交

2014年9月11日

首先提交符合 QC 标准的

2014年9月26日

首次发布 (估计)

2014年9月30日

研究记录更新

最后更新发布 (估计)

2015年12月28日

上次提交的符合 QC 标准的更新

2015年12月23日

最后验证

2015年12月1日

更多信息

与本研究相关的术语

其他研究编号

  • 2014-A00091-46

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

在美国制造并从美国出口的产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅